Goldstein Advisors LLC Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Goldstein Advisors LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,215 shares of the healthcare conglomerate’s stock after selling 138 shares during the period. Goldstein Advisors LLC’s holdings in UnitedHealth Group were worth $614,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. APG Asset Management US Inc. grew its holdings in shares of UnitedHealth Group by 5.3% during the 2nd quarter. APG Asset Management US Inc. now owns 351,983 shares of the healthcare conglomerate’s stock worth $174,108,000 after purchasing an additional 17,747 shares during the period. Ameriprise Financial Inc. boosted its stake in UnitedHealth Group by 0.6% during the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock worth $1,920,039,000 after buying an additional 21,149 shares during the period. Employees Retirement System of Texas raised its stake in shares of UnitedHealth Group by 9.2% in the 2nd quarter. Employees Retirement System of Texas now owns 198,670 shares of the healthcare conglomerate’s stock valued at $101,175,000 after acquiring an additional 16,800 shares during the period. Eminence Capital LP acquired a new stake in UnitedHealth Group in the 2nd quarter valued at approximately $26,657,000. Finally, Drucker Wealth 3.0 LLC purchased a new stake in UnitedHealth Group in the second quarter valued at approximately $1,062,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.33% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Barclays lowered their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Trading Up 1.8 %

NYSE:UNH opened at $528.94 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market capitalization of $486.77 billion, a price-to-earnings ratio of 34.12, a PEG ratio of 1.41 and a beta of 0.62. The stock has a fifty day moving average price of $543.52 and a two-hundred day moving average price of $563.78.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business posted $5.83 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.59%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.